Remember...this ran from around $3 to $21 in a few days in anticipation of these same positive results that were announced yesterday. Now we got the clinical data needed. Should run again, no?
The shorts were all over it when they took it down to $3 and denied is all a bounce.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.